IDEXX Laboratories, Inc.
IDXX · Nasdaq
- $504.70
- $40.14B
- Open
- —
- —
- $505.02 - $515.48
- $500.61 - $769.98
- —
- —
- 454.11K
About IDEXX Laboratories, Inc.
IDEXX Laboratories sells veterinary diagnostic products and services, practice-management and other software, and water-testing solutions. Its customers include veterinary practices and laboratories, while its water business serves customers needing water-quality testing. The company makes money from recurring and transactional demand for diagnostic instruments, tests, software, and related services, although the supplied evidence does not provide segment revenue percentages. IDEXX generated $4.3 billion of revenue and $1.1 billion of net income in FY2025, up from $3.9 billion and $0.9 billion, respectively, in FY2024.
Notable Price Movement
- Aug 3-7$586.674.94%
IDXX rose $18.55, or 3.26%, over the reported week, from $569.54 to $588.09. The stock initially drifted sideways, then fell $10.97 on July 30 and remained essentially flat on July 31. It recovered 1.57% on August 3 before surging 3.57% on August 4, when IDEXX reported second-quarter results. The main catalyst was a quarterly earnings and revenue beat, including an 8.10% earnings surprise and a 1.28% revenue surprise, alongside higher profit, margin expansion, and an increase in full-year EPS guidance. Diagnostics demand and adoption supported the outlook, although the company narrowed its full-year revenue outlook. Trading volume more than doubled on August 3-4, confirming the earnings-driven move.
